LNM is a critical factor in EECs that influences their course and prognosis. Furthermore, the histological grade of an EEC is frequently considered for prognostic and therapeutic purposes. In contrast to cervical adenocarcinoma, there is currently no reliable histological grading system other than the Silva system for patients with EEC that stratifies the risk of LNM. Our study analyzed the histopathological features of EECs comprehensively to develop a nomogram that can assist clinicians in stratifying the risk of LNM. In the current study, we defined the parameters of a nomogram, which included LVI, high-grade pattern, and mitosis, for the prediction of LNM. As such, we established a novel and reliable nomogram and compared it with the traditional grading systems to show its ability to stratify the risk of LNM and to assist the surgeons in choosing the best surgical method to minimize the loss of patients during operations.
Although the traditional Silverberg and FIGO histological grading systems have been proven to have good prognostic risk stratification in many datasets [5], herein, they were unable to effectively predict LNM in patients with EEC. By integrating the original Silverberg and FIGO histological factors, we identified MELF pattern and necrosis as valuable factors for optimizing the stratification of LNM risk. Our nomogram can be stratified such that low-risk patients can avoid lymph node dissection and improve their postoperative quality of life and high-risk patients can receive appropriate postoperative adjuvant therapy.
LVI, as a traditional prognostic factor, is strongly associated with LNM; thus, it was included in the Silva grading system for cervical adenocarcinoma. A high-grade pattern is defined as solid, micropapillary, fused glands or single cells infiltrating the desmoplastic stroma. Furthermore, high-grade patterns have been shown to have prognostic significance in many cancers, including lung adenocarcinoma [6] and cervical adenocarcinoma [7]. High mitotic counts have been shown to have prognostic significance not only in cancerous tumors but also in various other tumor types. Moreover, they play an important role in differentiating benign and malignant mesenchymal tumors. However, the traditional grading system only included a high-grade pattern and high mitotic count while excluding micropapillary fused glands or single-cell patterns and LVI. The results of the present study showed that a novel nomogram that contains LVI and high-grade patterns can provide more reliable risk stratification. Furthermore, we incorporated the proportion of high-grade patterns and the number of mitotic cells as continuous variables into the nomogram; thus, this scoring system may be more objective and feasible in routine practice.
Tumor necrosis results from rapid cell proliferation and overgrowth of blood supply, leading to hypoxia in tumor cells [8]. Tumor necrosis has been demonstrated to correlate with invasiveness and adverse clinical outcomes in many cancers, including carcinomas [9], although its prognostic relevance in EECs has not yet been defined. The presence of tumor necrosis resulting in necrotic/tumor debris within the tumor gland lumen may reflect the tumor biology and provide valuable prognostic information. The association between the MELF pattern and LNM has been investigated previously [10]. Some studies have shown that patients with the MELF pattern have a higher prevalence of LNM than those without the MELF pattern [10,11,12]. Furthermore, the MELF pattern is related to an advanced FIGO stage and adverse histological findings [10]. These results suggest that the MELF pattern is a concomitant finding that appears in association with tumor progression. Our results agree with previously reported findings and indicate that tumor necrosis/tumors and a MELF pattern are of significant prognostic value for EECs. Although the MELF pattern and necrosis were not significant independent predictors in our multivariate analysis, their inclusion in the nomogram confirmed more accurate risk stratification.
Our study also examined the prognostic value of the tumor stroma in EC. However, this did not play a role in predicting LNM in the nomogram. Importantly, our nomogram incorporated several new histological indicators (LVI, MELF pattern, and necrosis) for ruling out high-grade nuclei. Adjuvant therapy for advanced-stage EC is also a debated topic globally. The use of radiation decreases local recurrence rates without improving distant failures; however, chemotherapy alone decreases distant failure rates without improving local control [13, 14]. Management of early-stage EC has evolved during the past two decades. The use of adjuvant treatments remains somewhat controversial, partly due to low recurrence rates after surgery alone, although upfront surgery has remained the mainstay of treatment. Pathological evaluation is an important basis for oncologists to choose postoperative adjuvant therapy, especially pathological lymph node evaluation [15]. Our model can not only effectively stratify the risk of LNM, but also predict a high risk of recurrence in patients without LNM. Patients with high-risk ECs, especially in the early stages, should receive postoperative adjuvant therapy. However, this study also has some limitations. First, the statistical power was limited because this was a retrospective single-center study. Second, owing to the retrospective study design, potential selection bias could not be excluded. Third, the sample size was small, and there was no external validation. Finally, although the study focused on identifying the most significant predictors of LNM, it is unclear whether the findings can be generalized.